BLK
69
2
AMAT
49
-3
ADI
56
-3
JBHT
49
3
FAST
46
-2
GT
46
3
V
64
-4
HUM
30
3
APD
42
-2
FTI
69
-7
CCL
71
4
WU
16
2
PX
52
-3
INTC
37
-4
AN
49
2
IR
69
-2
PAYX
53
-4
ABBV
51
-2
HSIC
56
3
PWR
60
-2
BLK
69
2
AMAT
49
-3
ADI
56
-3
JBHT
49
3
FAST
46
-2
GT
46
3
V
64
-4
HUM
30
3
APD
42
-2
FTI
69
-7
CCL
71
4
WU
16
2
PX
52
-3
INTC
37
-4
AN
49
2
IR
69
-2
PAYX
53
-4
ABBV
51
-2
HSIC
56
3
PWR
60
-2
Financhill
Back

Arrowhead Pharmaceuticals Quote, Financials, Valuation and Earnings

"EarnPhone": The Investment Hidden in Plain Sight

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20

ARWR
Arrowhead Pharmaceuticals

Last Price:
21.14
Seasonality Move:
6.36%

7 Day Trial

ALL ACCESS PASS

$ 7

Free 23-page book shares my #1 indicator to use

Here's the 23-page free book.

Arrowhead Pharmaceuticals Price Quote

$21.14
+0.36 (+1.73%)
(Updated: September 19, 2024 at 4:40 PM ET)

Arrowhead Pharmaceuticals Key Stats

Sell
20
Arrowhead Pharmaceuticals (ARWR) is a Sell
Day range:
$19.79 - $21.36
52-week range:
$19.44 - $39.83
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
13.21
P/B ratio:
7.82%
Volume:
1.4M
Avg. volume:
1.1M
1-year change:
-26.13%
Market cap:
$2.6B
Revenue:
$240.7M
EPS:
$-4.66

How Much Does Arrowhead Pharmaceuticals Make?

Data Unavailable

Is Arrowhead Pharmaceuticals Growing As A Company?

Data Unavailable

Arrowhead Pharmaceuticals Stock Price Performance

What Is Arrowhead Pharmaceuticals 52-Week High & Low?

Arrowhead Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Arrowhead Pharmaceuticals?

Is Arrowhead Pharmaceuticals Cash Flow Positive?

  • What Is ARWR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$351.6M
  • What Is Arrowhead Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $482.3M
  • What Is Arrowhead Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$166.6M

Arrowhead Pharmaceuticals Return On Invested Capital

Data Unavailable

Arrowhead Pharmaceuticals Earnings Date & Stock Price

Arrowhead Pharmaceuticals Competitors

Arrowhead Pharmaceuticals Dividend Yield

Arrowhead Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -134.53%
Revenue: 0% -100%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 47.29
Upside from Last Price: 127.55%

Major Shareholders

  • How many ARWR shares are owned by institutional investors?
    149.6M ARWR shares are owned by institutional investors
  • How many ARWR shares are owned by insiders?
    7.8M ARWR shares are owned by insiders